Patent Assignment
Reel/Frame 032448/0045
Release of Security Interest
Recorded: 2014-03-14
Pages: 10
Assignor
LFB BIOTECHNOLOGIES S.A.S.U.
Executed: 2014-03-11
Assignee
GTC BIOTHERAPEUTICS, INC.
175 CROSSING BOULEVARD, FRAMINGHAM, MASSACHUSETTS, 01702
Covered Properties
(44)
Transgenic Animals Secreting Desired Proteins into Milk
Patent:
7,939,317 →
Application:
07/839,194 →
Transgenic Animals Secreting Proteins into Milk
Patent:
7,045,676 →
Application:
07/938,322 →
Inhibitor-Resistant Urokinase
Patent:
5,648,253 →
Application:
07/942,157 →
The Production of Fat Globule Proteins in the Milk of Transgenic Nonhuman Mammals
Patent:
6,448,469 →
Application:
08/088,416 →
Transgenic Production of Antibodies in Milk
Patent:
5,827,690 →
Application:
08/170,579 →
Transgenic Animals Secreting Desired Proteins into Milk
Patent:
6,727,405 →
Application:
08/246,259 →
Process for the Sterile Filtration of Milk
Patent:
5,576,040 →
Application:
08/282,256 →
Isolation of Components of Interest from Milk
Patent:
5,756,687 →
Application:
08/376,620 →
Transgenically Produced Antithrombin Iii
Patent:
5,843,705 →
Application:
08/391,743 →
Transgenic Production of Antibodies in Milk
Patent:
5,849,992 →
Application:
08/410,887 →
Purification of Biologically Active Peptides from Milk
Patent:
6,268,487 →
Application:
08/648,235 →
Transgenic Production of Antibodies in Milk
Application:
09/012,904 →
Publication:
US 2004/0006776
Transgenically Produced Non-Secreted Proteins
Patent:
6,528,699 →
Application:
09/028,551 →
Transgenically Produced Antithrombin Iii
Patent:
6,441,145 →
Application:
09/143,155 →
Novel Modified Nucleic Acid Sequences and Methods for Increasing Mrna Levels and Protein Expression in Cell Systems
Patent:
7,632,980 →
Application:
09/175,683 →
Novel Modified Msp-1 Nucleic Acid Sequences and Methods for Increasing Mrna Levels and Protein Expression in Cell Systems
Patent:
6,593,463 →
Application:
09/175,684 →
Methods of Reconstructed Goat Embryo Transfer
Patent:
6,580,017 →
Application:
09/298,971 →
Erythropoietin Analog-Human Serum Albumin Fusion
Patent:
6,548,653 →
Application:
09/333,213 →
Transgenically Produced Prolactin
Patent:
6,545,198 →
Application:
09/490,657 →
The Production of Membrane Proteins in the Milk of Transgenic Mammals
Patent:
6,472,584 →
Application:
09/627,290 →
Erythropoietin Analog-Human Serum Albumin Fusion
Non-Human Transgenic Mammal Comprising a Modified Msp-1 Nucleic Acid
Production of Membrane Proteins in the Milk of Transgenic Mammals
Method for the Crystallization of Human Serum Albumin
Treatment of lung disorders
Application:
10/396,855 →
Publication:
US 2004/0192595
Transgenic and cloned mammals
Application:
10/423,792 →
Publication:
US 2003/0177513
Enhancement of Immune Responses by 4-1BB-Binding Agents
Method of using recombinant human antithrombin for neurocognitive disorders
Application:
10/835,836 →
Publication:
US 2005/0245444
Method for the Production of Fusion Proteins in Transgenic Mammal Milk
Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
Application:
10/949,975 →
Publication:
US 2005/0071890
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
Application:
11/007,852 →
Publication:
US 2006/0130159
Methods of protein fractionation using high performance tangential flow filtration
Application:
11/051,216 →
Publication:
US 2005/0197496
Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
Application:
11/057,522 →
Publication:
US 2005/0192226
Anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof
Application:
11/058,458 →
Publication:
US 2006/0182744
Compositions and methods for prevention of photoaging
Application:
11/060,041 →
Publication:
US 2005/0208000
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
Application:
11/061,295 →
Publication:
US 2006/0188439
Merozoite Surface Protein 1 Lacking Glycosylation Sites
Transgenically Produced Antithrombin Iii
Clarification of Transgenic Milk Using Depth Filtration
Method for the crystallization of human serum albumin
Application:
11/378,727 →
Publication:
US 2006/0178309
Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
Application:
11/586,431 →
Publication:
US 2008/0118501
A non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
Application:
12/050,569 →
Publication:
US 2009/0246194
Treatment And Prophylaxis With 4-1BB-Binding Agents
Application:
12/269,462 →
Publication:
US 2009/0068193
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 24, 2011
From: GORDON, KATHERINE; GROET, SUZANNE
To: INTEGRATED GENETICS, INC.
Reel/Frame 026013/0512 →
Assignment of Assignor's Interest
Mar 24, 2011
From: GORDON, KATHERINE; GROET, SUZANNE
To: INTEGRATED GENETICS, INC.
Reel/Frame 026013/0450 →
Assignment of Assignor's Interest
Mar 24, 2011
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION
Reel/Frame 026013/0581 →
Assignment of Assignor's Interest
Mar 24, 2011
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION
Reel/Frame 026013/0472 →
Corrective Assignment to Correct the Assignment Recordation Previously Recorded on Reel 011497 Frame 0572. Assignor(S) Hereby Confirms the Execution Date Should Be Listed as 12/07/2000.
Jan 18, 2013
From: MOLLER, WOLFGANG
To: GENZYME TRANSGENICS CORPORATION
Reel/Frame 029660/0539 →
Change of Name
Jul 18, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 030831/0075 →
Corrective Assignment to Correct the Application Number 08232256 to 08282256 Previously Recorded on Reel 030831, Frame 0075. Assignors Hereby Confirms the Application Number.
Jul 31, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031012/0924 →
Corrective Assignment to Correct the Application Number 08232256, to 08282256, Previously Recorded on Reel 030831, Frame 0075.
Aug 13, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031161/0462 →
Corrective Assignment to Correct the Assignment Recordation Previously Recoded on Reel 030831, Frame 0075. Assignors Hereby Confirms the Following Application Number Was Incorrectly Inputted as 08232256 and Confirms the Change of Name.
Aug 15, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031058/0292 →
Change of Name
Aug 15, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031030/0152 →
Release of Security Interest
Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Assignment of Assignor's Interest
May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0091 →
Assignment of Assignor's Interest
May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0084 →
Assignment of Assignor's Interest
May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0099 →
Assignment of Assignor's Interest
May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0217 →
Assignment of Assignor's Interest
May 16, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032916/0675 →
Assignment of Assignor's Interest
May 16, 2014
From: GENZYME CORPORATION
To: GENZYME TRANSGENICS CORPORATION
Reel/Frame 032916/0672 →
Assignment of Assignor's Interest
May 16, 2014
From: MEADE, HARRY; POLLOCK, DANIEL; DITULLIO, PAUL
To: GENZYME CORPORATION
Reel/Frame 032916/0638 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →